Clinical Trial Update: Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment [NA]

View source ↗

Summary

Ongoing clinical trial evaluating recombinant human thyroid-stimulating hormone (rhTSH) to facilitate Radioiodine 131I treatment in differentiated thyroid cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Recombinant Human Thyroid Stimulating Hormone (thyrotropin alfa)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: DTC - Differentiated Thyroid Cancer, Thyroid Stimulating; Hormone, C | NA | Status: RECRUITING